Its approval rests on two multicenter, randomized, double-blind, placebo-controlled trials in patients with erythropoietic protoporphyria one conducted in Europe and one in the United States in which the afamelanotide implant increased the amount of pain-free time patients could spend in sunlight and was generally well tolerated, with adverse events that were mostly mild
Changing your life takes more than willpowerit takes the right support
as the first therapy to help people manage their weight and reduce cardiovascular risks, Martin Holst Lange, executive vice president and head of development at Novo Nordisk, said in a separate statement
Do not use if you are allergic to any ingredients
Digestive disorders: Some people may experience digestive disorders, such as nausea, vomiting or diarrhea
GHRH analogs (sermorelin and tesamorelin) imitate the body's own releasing hormone and bind the GHRH receptor, so the pituitary responds the way it would to a natural signal